Mean platelet volume may predict early clinical outcome after coronary artery bypass grafting

Ertekin Utku Unal, Anil Ozen, Sabit Kocabeyoglu, Ahmet Baris Durukan, Sercan Tak, Murat Songur, Umit Kervan, Cemal Levent Birincioglu, Ertekin Utku Unal, Anil Ozen, Sabit Kocabeyoglu, Ahmet Baris Durukan, Sercan Tak, Murat Songur, Umit Kervan, Cemal Levent Birincioglu

Abstract

Background: An elevated mean platelet volume is associated with increased platelet activation and thus may predict thrombotic events. The goal of this study was to investigate the association of the mean platelet volume and the major adverse events after coronary artery bypass surgery.

Methods: Baseline clinical details and preoperative hematologic parameters were obtained prospectively in 205 consecutive patients undergoing coronary artery bypass surgery. Postoperative mortality and major adverse events were recorded in the early postoperative period (median of 72 days, interquartile range 58.5-109 days).

Results: Combined adverse events occurred in 37 patients (18.0%) during the early follow-up. The preoperative mean platelet volume and hematocrit levels were found to be associated with postoperative adverse events (p<0.001 for both variables). In multivariate logistic regression models, the preoperative mean platelet volume and hematocrit levels were strong independent predictors of combined adverse events after surgery (respectively OR 1.89, p=0.037; OR 0.87, p=0.011). After receiver-operating-characteristics curve analysis, using a cut-point of 8.75 fL, the preoperative mean platelet volume level predicted adverse events with a sensitivity of 54% and specificity of 70%. In a further model with cut-off points, higher preoperative mean platelet volume levels remained a powerful independent predictor of postoperative myocardial infarction (OR 3.60, p=0.013) and major adverse cardiac events (OR 2.53, p=0.045).

Conclusions: An elevated preoperative mean platelet volume is associated with an adverse outcome after coronary artery bypass grafting. In conclusion, we can say that mean platelet volume is an important, simple, readily available, and cost effective tool and can be useful in predicting the postoperative adverse events in patients undergoing coronary artery bypass grafting.

References

    1. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg. 1999;15:816–822. doi: 10.1016/S1010-7940(99)00106-2.
    1. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482–2494. doi: 10.1056/NEJMra071014.
    1. Slavka G, Perkmann T, Haslacher H, Greisenegger S, Marsik C, Wagner OF, Endler G. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol. 2011;31:1215–1218. doi: 10.1161/ATVBAHA.110.221788.
    1. Wang RT, Li Y, Zhu XY, Zhang YN. Increased mean platelet volume is associated with arterial stiffness. Platelets. 2011;22:447–451. doi: 10.3109/09537104.2011.565431.
    1. Varol E, Aksoy F, Ozaydin M, Erdogan D, Dogan A. Relationship between mean platelet volume and mitral annular calcification. Blood Coagul Fibrinolysis. 2013;24:189–193.
    1. Guven A, Caliskan M, Ciftci O, Barutcu I. Increased platelet activation and inflammatory response in patients with masked hypertension. Blood Coagul Fibrinolysis. 2013;24:170–174.
    1. Tavil Y, Sen N, Yazici HU, Hizal F, Açikgöz SK, Turfan M, Cengel A. Relationship between elevated platelet volume and saphenous vein graft disease. Clin Invest Med. 2010;33:E161–E167.
    1. Erdem K, Ayhan S, Ozturk S, Bugra O, Bozoglan O, Dursin H, Yazici M, Daglar B. Usefulness of the mean platelet volume for predicting new-onset atrial fibrillation after isolated coronary bypass grafting. Platelets. 2013. p. . Epub ahead of print.
    1. Zindrou D, Taylor KM, Bagger JP. Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. Lancet. 2002;359:1747–1748. doi: 10.1016/S0140-6736(02)08614-2.
    1. Fang WC, Helm RE, Krieger KH, Rosengart TK, DuBois WJ, Sason C, Lesser ML, Isom OW, Gold JP. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation. 1997;96(Suppl 9):194–199.
    1. Ferraris VA, Ferraris SP. Risk factors for postoperative morbidity. J Thorac Cardiovasc Surg. 1996;111:731–738. doi: 10.1016/S0022-5223(96)70333-1.
    1. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–2351. doi: 10.1161/CIRCULATIONAHA.106.685313.
    1. Hannan EL, Kilburn H Jr, O'Donnell JF, Lukacik G, Shields EP. Adult open heart surgery in New York State. An analysis of risk factors and hospital mortality rates. JAMA. 1990;264:2768–2774. doi: 10.1001/jama.1990.03450210068035.
    1. O'Connor GT, Plume SK, Olmstead EM, Coffin LH, Morton JR, Maloney CT, Nowicki ER, Levy DG, Tryzelaar JF, Hernandez F. Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery. Northern New England Cardiovascular Disease Study Group. Circulation. 1992;85:2110–2118. doi: 10.1161/01.CIR.85.6.2110.
    1. Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP. Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88(Suppl 1):2–22.
    1. Bell ML, Grunwald GK, Baltz JH, McDonald GO, Bell MR, Grover FL, Shroyer AL. Does preoperative hemoglobin independently predict short-term outcomes after coronary artery bypass graft surgery? Ann Thorac Surg. 2008;86:1415–1423. doi: 10.1016/j.athoracsur.2008.07.088.
    1. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA, Moehnle P, Mangano DT. Investigators of the Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation. 2007;116:471–479. doi: 10.1161/CIRCULATIONAHA.106.653501.
    1. Bagger JP, Zindrou D, Taylor KM. Leukocyte count: a risk factor for coronary artery bypass graft mortality. Am J Med. 2003;115:660–663. doi: 10.1016/S0002-9343(03)00438-8.
    1. Gibson PH, Croal BL, Cuthbertson BH, Small GR, Ifezulike AI, Gibson G, Jeffrey RR, Buchan KG, El-Shafei H, Hillis GS. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J. 2007;154:995–1002. doi: 10.1016/j.ahj.2007.06.043.
    1. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet. 1991;338:1409–1411. doi: 10.1016/0140-6736(91)92719-I.
    1. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010;8:148–156. doi: 10.1111/j.1538-7836.2009.03584.x.
    1. Dogan A, Aksoy F, Icli A, Arslan A, Varol E, Uysal BA, Ozaydin M, Erdogan D. Mean platelet volume is associated with culprit lesion severity and cardiac events in acute coronary syndromes without ST elevation. Blood Coagul Fibrinolysis. 2012;23:324–330. doi: 10.1097/MBC.0b013e328352cb21.
    1. Zakkar M, Taylor K, Hornick PI. In: Cardiopulmonary Bypass: Principles And Practice. 3rd Edition. Gravlee GP, Davis RF, Stammers AH, Ungerleider RM, editor. Philadelphia: Lippincott Williams & Wilkins; 2008. Immune system and inflammatory responses to cardiopulmonary bypass; pp. 321–337.
    1. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivoby P-selectin on adherent platelets. Nature. 1992;359:848–851. doi: 10.1038/359848a0.
    1. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998;391:591–594. doi: 10.1038/35393.
    1. Mahla E, Suarez TA, Bliden KP, Rehak P, Metzler H, Sequeira AJ, Cho P, Sell J, Fan J, Antonino MJ, Tantry US, Gurbel PA. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv. 2012;5:261–269. doi: 10.1161/CIRCINTERVENTIONS.111.967208.
    1. Gurbel PA, Mahla E, Tantry US. Peri-operative platelet function testing: the potential for reducing ischaemic and bleeding risks. Thromb Haemost. 2011;106:248–252. doi: 10.1160/TH11-02-0063.
    1. Steele P, Battock D, Pappas G, Genton E. Correlation of platelet survival time with occlusion of saphenous vein aorto-coronary bypass grafts. Circulation. 1976;53:685–687. doi: 10.1161/01.CIR.53.4.685.
    1. Al Falluji N, Lawrence-Nelson J, Kostis JB, Lacy CR, Ranjan R, Wilson AC. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J. 2002;144:636–641.
    1. Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, Hacke W. CAPRIE Investigators. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke. 2004;35:1147–1152. doi: 10.1161/01.STR.0000124122.71702.64.
    1. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, Renlund DG, Muhlestein JB. Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45:1638–1643. doi: 10.1016/j.jacc.2005.02.054.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться